148 related articles for article (PubMed ID: 4715636)
1. Voltage laterality in the EEG of psychiatric patients.
Serafetinides EA
Dis Nerv Syst; 1973 Mar; 34(3):190-1. PubMed ID: 4715636
[No Abstract] [Full Text] [Related]
2. Psychological effects of single-dose antipsychotic medication.
Serafetinides EA; Clark ML
Biol Psychiatry; 1973 Dec; 7(3):263-7. PubMed ID: 4586833
[No Abstract] [Full Text] [Related]
3. Laterality and voltage in the EEG of psychiatric patients.
Serafetinides EA
Dis Nerv Syst; 1972 Sep; 33(9):622-3. PubMed ID: 4649157
[No Abstract] [Full Text] [Related]
4. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
Serafetinides EA; Willis D; Clark ML
J Nerv Ment Dis; 1972 Nov; 155(5):366-9. PubMed ID: 4563078
[No Abstract] [Full Text] [Related]
5. [Clinical and EEG study (polygraph recording) of a new neuroleptic drug: Sordinol (clopenthixol)].
Urbani M; Costa P; Bergonzi P
Riv Sper Freniatr Med Leg Alien Ment; 1965 Oct; 89(5):1225-50. PubMed ID: 5860488
[No Abstract] [Full Text] [Related]
6. A clinical evaluation of clopenthixol.
Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
[No Abstract] [Full Text] [Related]
7. Clopenthixol in schizophrenia. Comparison of two groups of patients treated by the same drug.
Vinar O; Bastecký J; Taussigová D; Formánková M; Růzicka S
Act Nerv Super (Praha); 1967 Nov; 9(4):401-4. PubMed ID: 4889074
[No Abstract] [Full Text] [Related]
8. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
Serafetinides EA; Collins S; Clark ML
J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
[No Abstract] [Full Text] [Related]
9. Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients.
Bartolucci G; Lehmann HE; Ban TA; Lee H
Curr Ther Res Clin Exp; 1966 Dec; 8(12):581-4. PubMed ID: 4962727
[No Abstract] [Full Text] [Related]
10. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
[No Abstract] [Full Text] [Related]
11. QEEG alpha 1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients.
Galderisi S; Maj M; Mucci A; Bucci P; Kemali D
Biol Psychiatry; 1994 Mar; 35(6):367-74. PubMed ID: 8018782
[TBL] [Abstract][Full Text] [Related]
12. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
13. [Course of body temperature during injection therapy with neuroleptics. Statistical evaluation of data from a retrospective study].
Harder A; Modestin J; Steiner H
Schweiz Med Wochenschr; 1971 Jun; 101(22):828-31. PubMed ID: 5143576
[No Abstract] [Full Text] [Related]
14. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
Czobor P; Volavka J
J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770
[TBL] [Abstract][Full Text] [Related]
15. EEG changes in the treatment with octoclothepine in very high doses.
Misurec J; Náhunek K; Svestka J; Rodová A
Act Nerv Super (Praha); 1974; 16(4):244-5. PubMed ID: 4450997
[No Abstract] [Full Text] [Related]
16. [Dynamics of integral parameters of the background EEG during treatment with neuroleptics].
Bochkarev VK; Paniushkina SV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):258-64. PubMed ID: 6122319
[No Abstract] [Full Text] [Related]
17. Clopenthixol: a controlled trial in chronic hospitalized schizophrenic patients.
Kordas SK; Kazamias NG; Georgas JG; Papadokostakis JG
Br J Psychiatry; 1968 Jul; 114(512):833-6. PubMed ID: 4874163
[No Abstract] [Full Text] [Related]
18. Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations.
Saletu B; Itil TM; Arat M; Akpinar S
Int Pharmacopsychiatry; 1973; 8(4):193-207. PubMed ID: 4589638
[No Abstract] [Full Text] [Related]
19. A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.
Dehnel LL; Vestre ND; Schiele BC
Curr Ther Res Clin Exp; 1968 Apr; 10(4):169-76. PubMed ID: 4967871
[No Abstract] [Full Text] [Related]
20. Double blind study of an acridan derivative (SK & F 14336) versus chlorpromazine.
Chen CP; Tsuang MM
Curr Ther Res Clin Exp; 1968 May; 10(5):223-30. PubMed ID: 4967734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
